Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare

Keyphrases

• Healthcare 100%
• Angiotensin Receptor Blockers 100%
• United States 33%
• Health Systems 33%
• Healthcare Professionals 33%
• Safety Profile 33%
• Patient Engagement 33%
• Valsartan 33%
• Pharmaceutical Industry 33%
• Appropriate Responses 33%
• Manufacturing Process 33%
• Public Trust 33%
• Clinical Source 33%
• Expiration Date 33%
• Additional Guidance 33%
• Appropriate Behavior 33%
• Quality Check 33%
• Safety Messages 33%
• Drug Manufacturer 33%
• Lot number 33%
• Drug Recall 33%
• Voluntary Recall 33%
• Scientific Sources 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Angiotensin Receptor Antagonist 100%
• Malignant Neoplasm 33%
• Valsartan 33%
• Pharmaceutical Manufacturing 33%